Tags: credit suisseRemove, pharmaceuticalsRemove

China's second-biggest drug distributor prices its H-share offering below the mid-point, but at a modest 2.4% discount versus its A-shares.
By Anette Jönsson | 16 May 2011
The first two Hong Kong IPOs of size this year raise $255 million between them. Retail demand remains strong, triggering full clawbacks on both deals.
By Anette Jönsson | 29 January 2007
Hong Kong companies Wuyi Pharmaceutical and Meadville seek to raise a combined $265 million with trading debuts scheduled for the first two days of February.
By Anette Jönsson | 18 January 2007
1
Magazine
FinanceAsia Magazine
FinanceAsia
December 2011/January 2012